Oxford BioMedica
Discover Realise

Email alerts

We have several mailing lists which you can subscribe to. We use these to send out relevant updates regarding Oxford BioMedica. We will not share your information with anyone else.

You can unsubscribe at any time, and each email we send contains an unsubscribe button.



The LentiVector® platform currently underpins eight of our gene and cell therapy Priority programmes, Other candidates and Partnered/IP enabled and royalty bearing products

We believe

We have a unique contribution to make to healthcare and we believe gene therapy is the future